AD Clinical Trials in Plain Language

Clinical trials for AD explained in plain language.

Never miss a new study

Get alerted when new AD trials appear

Sign up with your email to follow new studies for AD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Terminated 1

New pill aims to slow Alzheimer's: phase 2 trial underway

Disease control Recruiting now

This Phase 2 trial tests whether TTYP01 tablets can slow cognitive decline in people with early Alzheimer's disease. About 180 participants aged 60-85 with mild cognitive impairment or mild dementia will receive either a low dose, high dose, or placebo for 78 weeks. Researchers w…

Matched conditions: AD

Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

AD

Get alerted when new AD trials appear

New pill aims to slow Alzheimer's: phase 2 trial underway